Stock Price Quote

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE1659.957.45 (+0.45 %)
PREV CLOSE ( ) 1652.50
OPEN PRICE ( ) 1670.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3093
TODAY'S LOW / HIGH ( )1648.50 1679.90
52 WK LOW / HIGH ( )766.05 1703.8
NSE1660.308.55 (+0.52 %)
PREV CLOSE( ) 1651.75
OPEN PRICE ( ) 1652.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 42384
TODAY'S LOW / HIGH( ) 1648.60 1666.00
52 WK LOW / HIGH ( )769.6 1704.25
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 66402323

Email info@lupin.com

Website www.lupin.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

10May Announcement under Regulation 30 (LOD
Intimation regarding grant of 5000 Stock Options under ESOP 2014.
09May Lupin informs about press release
Lupin has enclosed a Press Release as regards, appointment of Jeffrey Ki..
07May VA Tech Wabag, Lupin and Mastek to see
VA Tech Wabag has secured a repeat order from Office National De L’assai..
07May Lupin reports 52% rise in Q4 consolida
Lupin has reported results for fourth quarter (Q4) and year ended March..
07May Lupin informs about investor presentat
Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15)(a..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit3840.823260.9
Gross Profit 4281.6 27846.9
Operating Profit 7316.935657.9
Net Sales 33958.8146665

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26643.70 (0.58%)
M.Cap ( in Cr)56616.00
Pfizer (BSE)
peergroup  4473.85 (1.59%)
M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE)
peergroup  2355.75 (2.80%)
M.Cap ( in Cr)39907.83
Concord Biotech (BSE)
peergroup  1494.85 (4.43%)
M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE)
peergroup  1104.45 (5.00%)
M.Cap ( in Cr)111133.51

Shareholding Pattern

NON-INSTITUTION 6.93%
PROMOTERS 47.01%
MUTUAL FUNDS/UTI 16.82%
FI/BANKS/INSURANCE 10.02%
GOVERNMENT 0.01%
FII 0%

About Lupin Ltd.

Lupin Ltd. was incorporated in the year 1983. Its today's share price is 1659.95. Its current market capitalisation stands at Rs 75652.24 Cr. In the latest quarter, company has reported Gross Sales of Rs. 113193.3 Cr and Total Income of Rs.114688.5 Cr. The company's management includes Alfonso Zulueta, Jeffrey Kindler, R V Satam, Mark D McDade, Punita Kumar Sinha, K B S Anand, Jean-Luc Belingard, Ramesh Swaminathan, Nilesh Gupta, Vinita Gupta, Manju D Gupta.

It is listed on the BSE with a BSE Code of 500257 , NSE with an NSE Symbol of LUPIN and ISIN of INE326A01037. It's Registered office is at Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East)Mumbai-400055, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Arora & Arora, BSR & Co LLP, Deloitte Haskins & Sells, Deloitte Haskins & Sells LLP, Deloittee Haskins & Sells, SS Kapoor & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.